ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours

Christopher Coyle; Fay H. Cafferty; Samuel Rowley; Mairead Mackenzie; Lindy Berkman; Sudeep Gupta; C S Pramesh; Duncan Gilbert; Howard Kynaston; David Cameron; Richard H. Wilson; Alistair Ring; Ruth E. Langley

doi:10.1016/j.cct.2016.10.004

ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours

Christopher Coyle, Fay H. Cafferty, Samuel Rowley, Mairead Mackenzie, Lindy Berkman, Sudeep Gupta, C S Pramesh, Duncan Gilbert, Howard Kynaston, David Cameron, Richard H. Wilson, Alistair Ring, Ruth E. Langley

Deanery of Molecular, Genetic and Population Health Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	56-64
Journal	Contemporary Clinical Trials
Volume	51
DOIs	https://doi.org/10.1016/j.cct.2016.10.004 https://doi.org/10.1016/j.cct.2016.10.004
Publication status	Published - 21 Oct 2016

Access to Document

D cameron paper add
Open Access funded by Cancer Research UK, Under a Creative Commons license
Final published version, 1.03 MBLicence: Creative Commons: Attribution (CC-BY)

http://linkinghub.elsevier.com/retrieve/pii/S1551714416303652

Cite this

Coyle, C., Cafferty, F. H., Rowley, S., Mackenzie, M., Berkman, L., Gupta, S., Pramesh, C. S., Gilbert, D., Kynaston, H., Cameron, D., Wilson, R. H., Ring, A., & Langley, R. E. (2016). ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. Contemporary Clinical Trials, 51, 56-64. https://doi.org/10.1016/j.cct.2016.10.004, https://doi.org/10.1016/j.cct.2016.10.004

Coyle, Christopher ; Cafferty, Fay H. ; Rowley, Samuel ; Mackenzie, Mairead ; Berkman, Lindy ; Gupta, Sudeep ; Pramesh, C S ; Gilbert, Duncan ; Kynaston, Howard ; Cameron, David ; Wilson, Richard H. ; Ring, Alistair ; Langley, Ruth E. / ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. In: Contemporary Clinical Trials. 2016 ; Vol. 51. pp. 56-64.

@article{d59fc96d1011497eb9008dae505ca96f,

title = "ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours",

author = "Christopher Coyle and Cafferty, {Fay H.} and Samuel Rowley and Mairead Mackenzie and Lindy Berkman and Sudeep Gupta and Pramesh, {C S} and Duncan Gilbert and Howard Kynaston and David Cameron and Wilson, {Richard H.} and Alistair Ring and Langley, {Ruth E.}",

year = "2016",

month = oct,

day = "21",

doi = "10.1016/j.cct.2016.10.004",

language = "English",

volume = "51",

pages = "56--64",

journal = "Contemporary Clinical Trials",

issn = "1551-7144",

publisher = "Elsevier Inc.",

}

Coyle, C, Cafferty, FH, Rowley, S, Mackenzie, M, Berkman, L, Gupta, S, Pramesh, CS, Gilbert, D, Kynaston, H, Cameron, D, Wilson, RH, Ring, A & Langley, RE 2016, 'ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours', Contemporary Clinical Trials, vol. 51, pp. 56-64. https://doi.org/10.1016/j.cct.2016.10.004, https://doi.org/10.1016/j.cct.2016.10.004

ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. / Coyle, Christopher; Cafferty, Fay H.; Rowley, Samuel; Mackenzie, Mairead; Berkman, Lindy; Gupta, Sudeep; Pramesh, C S; Gilbert, Duncan; Kynaston, Howard; Cameron, David; Wilson, Richard H.; Ring, Alistair; Langley, Ruth E.

In: Contemporary Clinical Trials, Vol. 51, 21.10.2016, p. 56-64.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours

AU - Coyle, Christopher

AU - Cafferty, Fay H.

AU - Rowley, Samuel

AU - Mackenzie, Mairead

AU - Berkman, Lindy

AU - Gupta, Sudeep

AU - Pramesh, C S

AU - Gilbert, Duncan

AU - Kynaston, Howard

AU - Cameron, David

AU - Wilson, Richard H.

AU - Ring, Alistair

AU - Langley, Ruth E.

PY - 2016/10/21

Y1 - 2016/10/21

U2 - 10.1016/j.cct.2016.10.004

DO - 10.1016/j.cct.2016.10.004

M3 - Article

VL - 51

SP - 56

EP - 64

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

ER -

Coyle C, Cafferty FH, Rowley S, Mackenzie M, Berkman L, Gupta S et al. ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. Contemporary Clinical Trials. 2016 Oct 21;51:56-64. https://doi.org/10.1016/j.cct.2016.10.004, https://doi.org/10.1016/j.cct.2016.10.004